Slight drop in Q1 Johnson & Johnson orthopedic sales, hitting $2.3B: 5 key notes Featured

Written by  Laura Dyrda | Wednesday, 19 April 2017 10:42
Social sharing

Johnson & Johnson reported orthopedic sales dropped slightly in the first quarter of 2017.

Here are eight things to know:


1. Orthopedics sales dropped 0.7 percent in the first quarter, hitting $2.3 billion. U.S. sales were $1.2 billion, a nearly 1 percent decline, while international sales were only down 0.3 percent to $948 million.


2. The company's hip sales hit $352 million in the first quarter, up 2.9 percent over the same period last year. The U.S. sales were up 3 percent to $209 million; international hip sales were $143 million.


3. Knee sales in the U.S. were up 0.8 percent to $246 million, and there was a 4.8 percent growth in international knee sales, which hit $152 million. Overall, knee sales were up 2.3 percent to $398 million.


4. Spine sales dropped 3.6 percent to $933 million in the first quarter, driven by a 5.5 percent decline in U.S. spine sales. International spine sales dropped 1 percent.


5. Trauma sales were flat at $642 million in the first quarter. The company reported 2.6 percent growth in U.S. sales, which was offset by a 3.8 percent decrease in international trauma sales.

Last modified on Friday, 21 April 2017 19:25
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months